Office of the Commissioner of Lobbying of Canada
Registry of Lobbyists

Monthly Communication Report

12241-665702

Corporation: Merck Canada Inc.
Associated registration: 959141-12241-48
Communication date: 2025-12-02
Posted date: 2026-01-14

Designated Public Office Holders who participated in the communication: Annahat Kochhar, Policy Advisor
Office of the President of the Treasury Board, Treasury Board Of Canada Secretariat (TBS)

Hosai Zurmati Halim, Policy Advisor
President's Office, Treasury Board Of Canada Secretariat (TBS)

Elizabeth Wong, Policy Advisor
Treasury Board Of Canada Secretariat (TBS)
 
List of Details
Subject matter Detail
Health, Research and Development Canada's Access to Medicines Regime with respect to ensuring that the program allows for the delivery of timely access to needed medicines to the developing world supported by a business climate in Canada that continues to encourage research into further treatment and prevention of disease.
Science and Technology The government's Science and Technology strategy as it relates to the biopharmaceutical industry.
 
Communication Report amended on: 2026-01-14 previous entry: 12241-665651
Reason for amendment: Added 2 other GO attendees
 
Responsible Officer who filed this communication report: David D. Jones
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Date Modified: